500420 Share Price Performance
₹4,540.90
1378.70 (43.60%)
0.5% undervalued intrinsic discount
₹4,564.93
Fair Value
Price ₹4,540.90
AnalystConsensusTarget ₹4,564.93
Fair Value₹4,564.93
Share Pricen/a
Narrative Update • May 12
Torrent Pharmaceuticals Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 10 Fair Values set on narratives written by author
500420 Community Narratives
AN
Fair Value
·Fair Value ₹4.56k 0.5% undervalued intrinsic discount
Robust Indian And Brazilian Markets Will Unlock Potential
1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
Robust Indian And Brazilian Markets Will Unlock Potential
Key Takeaways Sustained branded market growth, strategic launches, and chronic disease focus are driving higher demand, market share, and improved earnings outlook. Expanding product pipelines, R&D investments, and broadening global presence support long-term revenue growth and margin enhancement.Read more
AN
₹4.56k
0.5% undervalued intrinsic discount
Fair Value
Revenue
25.9% p.a.
Profit Margin
15.63%
Future PE
55.11x
Price in 2029
₹6.49k
Trending Discussion
Recently Updated Narratives
AN
500420: New Metabolic Launches And Dividend Payouts Will Shape Balanced Outlook
Fair Value: ₹4.56k 0.5% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Torrent Pharmaceuticals Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- 63.91
- 75.77%
- 15.47%
- 84.2%
About 500420
- Founded
- 1959
- Employees
- 17059
- CEO
- WebsiteView website
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.
